Health & Biotech
Health & Biotech
MGC Pharma announces exciting new developments in the fight against COVID-19
Health & Biotech
Dr Boreham’s Crucible: Has Anteotech got Covid tests down to an ART form?
Experts
ScoPo’s Powerplays: Health sector trades sideways but M&A plays coloured the week
Health & Biotech
StockDoc Podcast: Wattle Health gears up to relaunch on the ASX in 2021
Health & Biotech
Neurotech just started world’s first THC-less cannabis study in autistic children
Health & Biotech
Weed Week: Finally, a cannabis drug is on Australia’s Pharmaceutical Benefits Scheme
Health & Biotech
Emyria to seek approval for trial evaluating MDMA to treat PTSD
Health & Biotech
How Dimerix is now playing a crucial role in the global fight against COVID-19
Health & Biotech
Phillip Morris mulls cannabis, pot market gets up off the couch… almost
Health & Biotech
Recce, Botanix both announce progress on antimicrobial programs
Health & Biotech
MGC Pharma builds on momentum with a new $1 million order
Health & Biotech
Neurotech makes significant progress with world’s first cannabidiol drug for children with autism
Health & Biotech
Apiam gains traction with analysts, institutional investors and strategic partners as regional growth plans accelerate
Health & Biotech
Creso Pharma’s quarterly revenue surges 237%, with the huge US cannabis market now in sight
Experts
ScoPo’s Powerplays: A disappointing week for healthcare investors
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.